{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:10Z","timestamp":1762041610603,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with intestinal Beh\u00e7et\u2019s disease (BD) frequently undergo intestinal resections, which significantly affects postoperative morbidity and mortality. The aim of this study was to identify the association between C-reactive protein (CRP) levels and postoperative outcomes in patients with intestinal BD who underwent surgical bowel resection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients who were diagnosed with intestinal BD and underwent intestinal surgery due to BD at Severance Hospital between November 2005 and April 2018 were retrospectively investigated. Clinical relapse was defined as a disease activity index of BD (DAIBD)\u2009&gt;\u200940, existence of newly added medications, re-hospitalization, or re-operation related to intestinal BD. The relationship between CRP level and postoperative outcomes was analyzed, and a receiver operating characteristic (ROC) curve was drawn to specify a cut-off value.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>  Ninety patients with intestinal BD were included. Among them, 44 were male (48.9%), and the median age at diagnosis was 38 years (range, 11\u201369 years). The median total disease follow-up duration was 130 months (range, 3\u2013460 months). Forty patients (44.4%) underwent laparoscopic surgery. A higher CRP level immediately after surgery was significantly associated with postoperative complications (OR 1.01, 95% CI 1.004\u20131.018, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), re-operation (hazard ratio [HR] 1.01, 95% CI 1.005\u20131.020, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), and re-admission (HR 1.01, 95% CI 1.006\u20131.017 <jats:italic>p\u2009<\/jats:italic>&lt;\u20090.01). The ROC curve showed that CRP predicts the risk of postoperative complications (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) at a cut-off value of 41.9% with a sensitivity of 60.0% and specificity of 67.7%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Postoperative CRP levels in patients with intestinal BD undergoing surgical resection were associated with postoperative outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-021-01922-2","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T10:23:19Z","timestamp":1633602199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["C-reactive protein is associated with postoperative outcomes in patients with intestinal Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Eun Ae","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"17","key":"1922_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease. N Engl J Med. 1999;341(17):1284\u201391.","journal-title":"N Engl J Med"},{"issue":"1","key":"1922_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3904\/kjim.2017.377","volume":"33","author":"YE Park","year":"2018","unstructured":"Park YE, Cheon JH. Updated treatment strategies for intestinal Beh\u00e7et\u2019s disease. Korean J Intern Med. 2018;33(1):1\u201319.","journal-title":"Korean J Intern Med"},{"issue":"6","key":"1922_CR3","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.4049\/jimmunol.1801178","volume":"203","author":"H Petrushkin","year":"2019","unstructured":"Petrushkin H, Norman PJ, Lougee E, Parham P, Wallace GR, Stanford MR, Fortune F. KIR3DL1\/S1 allotypes contribute differentially to the development of Beh\u00e7et disease. J Immunol. 2019;203(6):1629\u201335.","journal-title":"J Immunol"},{"issue":"3","key":"1922_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"D Verity","year":"1999","unstructured":"Verity D, Marr J, Ohno S, Wallace G, Stanford M. Beh\u00e7et\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue antigens. 1999;54(3):213\u201320.","journal-title":"Tissue antigens"},{"issue":"8","key":"1922_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease. Nat Genet. 2010;42(8):698\u2013702.","journal-title":"Nat Genet"},{"issue":"3","key":"1922_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ard.55.3.208","volume":"55","author":"S Yurdakul","year":"1996","unstructured":"Yurdakul S, T\u00fcz\u00fcner N, Yurdakul I, Hamuryudan V, Yazici H. Gastrointestinal involvement in Beh\u00e7et\u2019s syndrome: a controlled study. Ann Rheum Dis. 1996;55(3):208\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1922_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","volume":"53","author":"SB Cho","year":"2012","unstructured":"Cho SB, Cho S, Bang D. New insights in the clinical understanding of Beh\u00e7et\u2019s disease. Yonsei Med J. 2012;53(1):35\u201342.","journal-title":"Yonsei Med J"},{"key":"1922_CR8","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease. Lancet. 1990;335(8697):1078\u201380.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"1922_CR9","doi-asserted-by":"crossref","unstructured":"Shimizu T, Ehrlich GE, Inaba G, Hayashi K: Beh\u00e7et disease (Beh\u00e7et syndrome). In: Seminars in arthritis and rheumatism: 1979: Elsevier; 1979: 223\u2013260.","DOI":"10.1016\/0049-0172(79)90004-0"},{"issue":"10","key":"1922_CR10","first-page":"2848","volume":"95","author":"M Naganuma","year":"2000","unstructured":"Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, Kanai T, Watanabe M, Hibi T. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Beh\u00e7et\u2019s disease. Am J Gastroenterol. 2000;95(10):2848\u201351.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1922_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/DCR.0000000000000373","volume":"58","author":"SJ Baek","year":"2015","unstructured":"Baek SJ, Kim CW, Cho MS, Jang HA, Baik SH, Hur H, Min BS, Kim NK. Surgical treatment and outcomes in patients with intestinal Beh\u00e7et disease: long-term experience of a single large-volume center. Dis Colon Rectum. 2015;58(6):575\u201381.","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"1922_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/ibd.21517","volume":"17","author":"YS Jung","year":"2011","unstructured":"Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet\u2019s disease. Inflamm Bowel Dis. 2011;17(7):1594\u2013602.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1922_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.5009\/gnl17547","volume":"12","author":"JW Park","year":"2018","unstructured":"Park JW, Park Y, Park SJ, Kim TI, Kim WH, Cheon JH. Development of a novel endoscopic scoring system to predict relapse after surgery in intestinal Beh\u00e7et\u2019s disease. Gut Liver. 2018;12(6):674\u201381.","journal-title":"Gut Liver"},{"issue":"1","key":"1922_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/BOR.0000000000000125","volume":"27","author":"JH Cheon","year":"2015","unstructured":"Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet\u2019s disease. Curr Opin Rheumatol. 2015;27(1):24\u201331.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1922_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5217\/ir.2017.15.3.311","volume":"15","author":"HJ Lee","year":"2017","unstructured":"Lee HJ, Cheon JH. Optimal diagnosis and disease activity monitoring of intestinal Beh\u00e7et\u2019s disease. Intest Res. 2017;15(3):311\u20137.","journal-title":"Intest Res"},{"issue":"10","key":"1922_CR16","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/ajg.2009.331","volume":"104","author":"JH Cheon","year":"2009","unstructured":"Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, Kim SW, Kim JS, Kim YS, Choi CH, Ye BD, et al. Development and validation of novel diagnostic criteria for intestinal Beh\u00e7et\u2019s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104(10):2492\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1922_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","volume":"30","author":"Y Bayraktar","year":"2000","unstructured":"Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet\u2019s disease. J Clin Gastroenterol. 2000;30(2):144\u201354.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1922_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10620-012-2351-9","volume":"58","author":"YS Jung","year":"2013","unstructured":"Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Clinical course of intestinal Behcet\u2019s disease during the first five years. Dig Dis Sci. 2013;58(2):496\u2013503.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"1922_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ibd.21313","volume":"17","author":"JH Cheon","year":"2011","unstructured":"Cheon JH, Han DS, Park JY, Ye BD, Jung SA, Park YS, Kim YS, Kim JS, Nam CM, Kim YN, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Beh\u00e7et\u2019s disease. Inflamm Bowel Dis. 2011;17(2):605\u201313.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1922_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000264643","volume":"81","author":"S K\u00f6kl\u00fc","year":"2010","unstructured":"K\u00f6kl\u00fc S, Y\u00fcksel O, Onur I, Unverdi S, Biyiko\u011flu I, Akbal E, Seng\u00fcl D, Unverdi H, Ek\u015fio\u011flu M. Ileocolonic involvement in Beh\u00e7et\u2019s disease: endoscopic and histological evaluation. Digestion. 2010;81(4):214\u20137.","journal-title":"Digestion"},{"issue":"3","key":"1922_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00054725-200108000-00010","volume":"7","author":"CR Lee","year":"2001","unstructured":"Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS, Bang D. Colonoscopic findings in intestinal Beh\u00e7et\u2019s disease. Inflamm Bowel Dis. 2001;7(3):243\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"1922_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00535-020-01690-y","volume":"55","author":"K Watanabe","year":"2020","unstructured":"Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, Arai K, Uchino M, Koganei K, Kobayashi T, et al. Evidence-based diagnosis and clinical practice guidelines for intestinal Beh\u00e7et\u2019s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol. 2020;55(7):679\u2013700.","journal-title":"J Gastroenterol"},{"issue":"7","key":"1922_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.dld.2018.10.024","volume":"51","author":"N Sugimura","year":"2019","unstructured":"Sugimura N, Mizoshita T, Sugiyama T, Togawa S, Miyaki T, Suzuki T, Tanida S, Kataoka H, Sasaki M. Real-world efficacy of adalimumab and infliximab for refractory intestinal Beh\u00e7et\u2019s disease. Dig Liver Dis. 2019;51(7):967\u201371.","journal-title":"Dig Liver Dis"},{"key":"1922_CR24","doi-asserted-by":"crossref","unstructured":"Kim JM, Kang JG, Kim S, Cheon JH. Deep-learning system for real-time differentiation between Crohn\u2019s disease, intestinal Beh\u00e7et\u2019s disease, and intestinal tuberculosis. J Gastroenterol Hepatol. 2021;36(8):2141-8.","DOI":"10.1111\/jgh.15433"},{"issue":"6","key":"1922_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.5009\/gnl17462","volume":"12","author":"J Park","year":"2018","unstructured":"Park J, Cheon JH. Anti-tumor necrosis factor therapy in intestinal Beh\u00e7et\u2019s disease. Gut Liver. 2018;12(6):623\u201332.","journal-title":"Gut Liver"},{"issue":"11","key":"1922_CR26","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/jgh.14690","volume":"34","author":"H Kinoshita","year":"2019","unstructured":"Kinoshita H, Nishioka H, Ikeda A, Ikoma K, Sameshima Y, Ohi H, Tatsuno M, Kouyama J, Kawamoto C, Mitsui T, et al. Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Beh\u00e7et\u2019s disease. J Gastroenterol Hepatol. 2019;34(11):1929\u201339.","journal-title":"J Gastroenterol Hepatol"},{"key":"1922_CR27","doi-asserted-by":"crossref","unstructured":"Suzuki Y, Hagiwara T, Kobayashi M, Morita K, Shimamoto T, Hibi T. Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Beh\u00e7et\u2019s disease: results from a large real-world observational study. Intest Res.\u00a02020.","DOI":"10.5217\/ir.2020.00013"},{"issue":"5","key":"1922_CR28","doi-asserted-by":"publisher","first-page":"e38-45","DOI":"10.1097\/MCG.0b013e3182431d56","volume":"46","author":"YS Jung","year":"2012","unstructured":"Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease. J Clin Gastroenterol. 2012;46(5):e38-45.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1922_CR29","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1097\/MCG.0b013e3181c8a50f","volume":"44","author":"MJ Chung","year":"2010","unstructured":"Chung MJ, Cheon JH, Kim SU, Park JJ, Kim TI, Kim NK, Kim WH. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Beh\u00e7et disease. J Clin Gastroenterol. 2010;44(6):e116-122.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"1922_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/BF02235590","volume":"43","author":"IJ Choi","year":"2000","unstructured":"Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY. Long-term clinical course and prognostic factors in intestinal Beh\u00e7et\u2019s disease. Dis Colon Rectum. 2000;43(5):692\u2013700.","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"1922_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF02604297","volume":"24","author":"Y Kasahara","year":"1981","unstructured":"Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Beh\u00e7et\u2019s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24(2):103\u20136.","journal-title":"Dis Colon Rectum"},{"key":"1922_CR32","doi-asserted-by":"crossref","unstructured":"Gong L, Zhang YL, Sun LX, Chen GR, Wu D. Mucosal healing in intestinal Beh\u00e7et\u2019s disease: a systematic review and meta-analysis. J Dig Dis. 2021;22(2):83-90.","DOI":"10.1111\/1751-2980.12965"},{"issue":"1","key":"1922_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/DCR.0b013e318238b57e","volume":"55","author":"YS Jung","year":"2012","unstructured":"Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Early versus late surgery in patients with intestinal Beh\u00e7et disease. Dis Colon Rectum. 2012;55(1):65\u201371.","journal-title":"Dis Colon Rectum"},{"issue":"16","key":"1922_CR34","doi-asserted-by":"publisher","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","volume":"95","author":"I Hatemi","year":"2016","unstructured":"Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet\u2019s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95(16):e3348.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1922_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13075-019-1933-8","volume":"21","author":"I Miyagawa","year":"2019","unstructured":"Miyagawa I, Nakano K, Iwata S, Nakayamada S, Saito K, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, et al. Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet\u2019s disease. Arthritis Res Ther. 2019;21(1):151.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1922_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00384-016-2743-y","volume":"32","author":"YE Park","year":"2017","unstructured":"Park YE, Cheon JH, Park J, Lee JH, Lee HJ, Park SJ, Kim TI, Kim WH. The outcomes and risk factors of early reoperation after initial intestinal resective surgery in patients with intestinal Beh\u00e7et\u2019s disease. Int J Colorectal Dis. 2017;32(4):591\u20134.","journal-title":"Int J Colorectal Dis"},{"issue":"9","key":"1922_CR37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/apt.14944","volume":"48","author":"C Auzolle","year":"2018","unstructured":"Auzolle C, Nancey S, Tran-Minh ML, Buisson A, Pariente B, Stefanescu C, Fumery M, Marteau P, Treton X, Hammoudi N, et al. Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn\u2019s disease: results from a prospective cohort study. Aliment Pharmacol Ther. 2018;48(9):924\u201332.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1922_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ibd.20872","volume":"15","author":"DB Sachar","year":"2009","unstructured":"Sachar DB, Lemmer E, Ibrahim C, Edden Y, Ullman T, Ciardulo J, Roth E, Greenstein AJ, Bauer JJ. Recurrence patterns after first resection for stricturing or penetrating Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15(7):1071\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"37","key":"1922_CR39","first-page":"152","volume":"48","author":"B Hofer","year":"2001","unstructured":"Hofer B, B\u00f6ttger T, Hernandez-Richter T, Seifert JK, Junginger T. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn\u2019s disease. Hepatogastroenterology. 2001;48(37):152\u20135.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"1922_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/BF02048274","volume":"39","author":"P Aeberhard","year":"1996","unstructured":"Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G. Surgical recurrence of perforating and nonperforating Crohn\u2019s disease. A study of 101 surgically treated Patients. Dis Colon Rectum. 1996;39(1):80\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"1922_CR41","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/jgh.13310","volume":"31","author":"YM Han","year":"2016","unstructured":"Han YM, Kim JW, Koh SJ, Kim BG, Lee KL, Im JP, Kim JS, Jung HC. Patients with perianal Crohn\u2019s disease have poor disease outcomes after primary bowel resection. J Gastroenterol Hepatol. 2016;31(8):1436\u201342.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1922_CR42","doi-asserted-by":"publisher","first-page":"e0179266","DOI":"10.1371\/journal.pone.0179266","volume":"12","author":"K Oh","year":"2017","unstructured":"Oh K, Oh EH, Baek S, Song EM, Kim GU, Seo M, Hwang SW, Park SH, Yang DH, Kim KJ, et al. Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn\u2019s disease. PLoS One. 2017;12(6):e0179266.","journal-title":"PLoS One"},{"issue":"1","key":"1922_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41598-020-57508-7","volume":"10","author":"H Shiga","year":"2020","unstructured":"Shiga H, Abe I, Onodera M, Moroi R, Kuroha M, Kanazawa Y, Kakuta Y, Endo K, Kinouchi Y, Masamune A. Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn\u2019s disease in Japan. Sci Rep. 2020;10(1):511.","journal-title":"Sci Rep"},{"issue":"1","key":"1922_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5217\/ir.2018.00048","volume":"17","author":"R Moroi","year":"2019","unstructured":"Moroi R, Endo K, Yamamoto K, Naito T, Onodera M, Kuroha M, Kanazawa Y, Kimura T, Kakuta Y, Masamune A, et al. Long-term prognosis of Japanese patients with biologic-na\u00efve Crohn\u2019s disease treated with anti-tumor necrosis factor-\u03b1 antibodies. Intest Res. 2019;17(1):94\u2013106.","journal-title":"Intest Res"},{"issue":"12","key":"1922_CR45","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00384-019-03427-7","volume":"34","author":"AS Ghoneima","year":"2019","unstructured":"Ghoneima AS, Flashman K, Dawe V, Baldwin E, Celentano V. High risk of septic complications following surgery for Crohn\u2019s disease in patients with preoperative anaemia, hypoalbuminemia and high CRP. Int J Colorectal Dis. 2019;34(12):2185\u20138.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"1922_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10620-016-4395-8","volume":"62","author":"J Zou","year":"2017","unstructured":"Zou J, Ji DN, Cai JF, Guan JL, Bao ZJ. Long-term outcomes and predictors of sustained response in patients with intestinal Behcet\u2019s disease treated with infliximab. Dig Dis Sci. 2017;62(2):441\u20137.","journal-title":"Dig Dis Sci"},{"issue":"6 Suppl 115","key":"1922_CR47","first-page":"90","volume":"36","author":"SN Esatoglu","year":"2018","unstructured":"Esatoglu SN, Hatemi I, Ozguler Y, Hatemi G, Uzun H, Celik AF, Yazici H. Faecal but not serum calprotectin levels look promising in predicting active disease in Beh\u00e7et\u2019s syndrome patients with gastrointestinal involvement. Clin Exp Rheumatol. 2018;36(6 Suppl 115):90\u20136.","journal-title":"Clin Exp Rheumatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01922-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T11:07:20Z","timestamp":1633604840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01922-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (IRB) of Yonsei University Health System, Severance Hospital, Seoul, Republic of Korea (IRB number: 4-2021-0078). This study was conducted in accordance with the ethical rules for human experimentation that stated in the Declaration of Helsinki.  The IRB of the Yonsei University Health System, Severance Hospital waived the need of informed consent due to the nature of retrospective observational study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests regarding this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}